Kidney Disease Clinical Trials

Showing 561-580 of 3,902 trials

Fluid Status of Dialysis Subjects

NCT07217041

The goal of this clinical pilot study is to evaluate the ability of the device to properly detect the hydration status of the subject through the study of fluid removal data during dialysis and HemoCept device data.

ESRD (End Stage Renal Disease)

HemoCept Inc.12 participantsStarted Mar 2025

Reno, Nevada, United States

Active Not RecruitingNA

The Home Blood Pressure (BP) Trial

NCT05159999

The main study will be a two arm 10-month, cross-over randomized controlled trial of 200 participants treated with end-stage-kidney-disease treated with in-center hemodialysis in the Seattle and San Francisco area comparing a strategy of targeting home vs. pre-dialysis systolic blood pressure \<140 mmHg to reduce rates of intradialytic hypotension. The target systolic blood pressure of \<140 mmHg in both treatment groups will be achieved using an algorithm of dry weight adjustment and anti-hypertensive medication adjustment.

End Stage Renal Disease on Dialysis

University of Washington200 participantsStarted Feb 2022

San Francisco, California, United States • Seattle, Washington, United States

RECRUITINGPhase 1

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

This study is a first-in-human (FIH), Phase 1/1b, open-label, multicenter dose escalation and dose expansion study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of JANX008 in adult subjects with advanced or metastatic carcinoma expressing EGFR.

Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more

Janux Therapeutics130 participantsStarted Apr 2023

Duarte, California, United States • Sacramento, California, United States • San Diego, California, United States +15 more locations

Fluid Status of Dialysis Subjects

The Home Blood Pressure (BP) Trial

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Related Searches

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Enhancing the Natriuretic Peptide System in HFpEF

The LARC Robot Simplifies Renal Access In Percutaneous Nephrolithotomy

Improving Patient Prioritization During Hospital-homecare Transition

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I

Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease

Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Care (NI-AKI)

Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)

Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

Deprescribing Intervention for Patients With Chronic Kidney Disease

3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation

Effects of Variation of Sodium Dialysate in ICU

A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province